Summary:
Click image to enlargeResearchers at Mt. Olympus Medical Research are enrolling adult participants into a clinical study, investigating if an investigational drug named lanifibranor will help in the treatment of NASH and the improvement of liver fibrosis (scarring). The investigational drug will be compared to a placebo, a pill that looks like the study drug, but does not contain an active medicine.
Criteria:- Be 18 years of age or older
- Have been diagnosed with or be at risk for NASH with fibrosis
- Have stable body weight in the last 6 months
- Be willing to have a liver biopsy
Qualified Participants May Receive:
There is no cost to participate and health insurance is not required to participate. Participants will receive the investigational medicine (lanifibranor) or placebo at no cost, as well as regular health assessments and trial-related tests and procedures. If eligible, you will also be closely monitored for your NASH and related medical conditions during the trial and receive regular medical care from healthcare providers with experience in NASH. Reimbursement for travel expenses and compensation for your loss of time may be available.